title: Sulfamethoxazole-trimethoprim (SMZ-TMP) as an effective therapy for Wegener's granulomatosis (WG)--three more cases.
authors.affiliation: Chru de Nancy, Hôpitaux de Brabois, Vandoeuvre, France.
authors.forename: B
authors.initials: B
authors.lastname: Hoen
authors.forename: B
authors.initials: B
authors.lastname: Aymard
authors.forename: A
authors.initials: A
authors.lastname: Gerard
authors.forename: A
authors.initials: A
authors.lastname: Brunet
authors.forename: P M
authors.initials: PM
authors.lastname: Mertes
authors.forename: T
authors.initials: T
authors.lastname: May
authors.forename: P
authors.initials: P
authors.lastname: Canton
authors.forename: J B
authors.initials: JB
authors.lastname: Dureux
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D015415:Biomarkers; D007074:Immunoglobulin G; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011241:Prednisone